SOLACI present at the 15 Symposium of Interventional Cardiology CardioInterv 2015

SOLACI express their gratitude to the Costantino Costantini Foundation, in Curitiba, Brazil, and to their director Dr. Costantino Costantini, for their invitation to take part in the 15 Symposium of Interventional Cardiology, CardioInterv 2015, held in Curitiba on November 26 thru 27, 2015.

The event, which took place at the Cardiology Center Costantini, proudly presented reputed international and Latin American guests and a program of outstanding scientific level. The activities included several live cases, round tables, case discussions and lectures from prestigious guests, such as doctors Andrés Íñiguez and José María de La Torre Hernández (Spain), Giulio Guagliumi and Imad Sheiban (Italy) and Jonathan M. Tobis (United States), among others.

Just like the previous year, our Society displayed a stand in the exhibition hall of the event.

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...